Reaction
Disability Assessment Scale Score Increased reporting signals
As of the last recalculation, Disability Assessment Scale Score Increased appears in 307 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TOCILIZUMAB (PRR 1,246.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tocilizumab | 268 | 1,246.7 | 1,249.6 |
| Dimenhydrinate | 18 | 121.6 | 121.8 |
| Desoximetasone | 24 | 92.6 | 92.7 |
| Losartan Potassium And Hydrochlorothiazide | 12 | 72.9 | 72.9 |
| Tranexamic Acid | 9 | 70.6 | 70.7 |
| Hydrocortisone Sodium Succinate | 8 | 59.2 | 59.3 |
| Sulfasalazine | 55 | 57.8 | 57.9 |
| Hydroxychloroquine Sulfate | 61 | 56.4 | 56.4 |
| Ketoprofen | 10 | 53.4 | 53.4 |
| Canagliflozin | 8 | 18.6 | 18.6 |